Photophysicochemical behavior and antimicrobial activity of dihydroxosilicon tris (diaquaplatinum) octacarboxyphthalocyanine

Platination of dihydroxosilicon octacarboxyphthalocyanine (OH)2SiOCPc was successfully carried out to give dihydroxosilicon tris(diaquaplatinum)octacarboxyphthalocyanine (OH)2SiOCPc(Pt)3 conjugate. Slight blue shifting of the absorption spectrum of (OH)2SiOCPc(Pt)3 was observed on conjugation with platinum. Comparative photophysicochemical behavior and antimicrobial photo-activities of (OH)2SiOCPc(Pt)3 conjugate with (OH)2SiOCPc or Pt nanoparticles revealed that the heavy atom, Pt on the periphery of the phthalocyanine significantly enhanced its singlet oxygen generation with a quantum yield of 0.56 obtained for the (OH)2SiOCPc(Pt)3 conjugate. The (OH)2SiOCPc(Pt)3 conjugate showed highest antimicrobial activity towards Candida albicans and Escherichia coli compared to (OH)2SiOCPc and Pt nanoparticles alone under illumination

Theoretical and photodynamic therapy characteristics of heteroatom doped detonation nanodiamonds linked to asymmetrical phthalocyanine for eradication of breast cancer cells

An amide mono substituted benzothiozole phthalocyanine: zinc(II) 3-(4-((3,17,23-tris(4-(benzo [d]thiazol-2-yl)phenoxy)-9-yl)oxy) phenyl)amide phthalocyanine (NH2BzPc) was covalently linked to undoped and heteroatom doped detonation nanodiamonds (DNDs): B@DNDs, P@DNDs, S@DNDs, N@DNDs, and SandN@DNDs There is a drastic decrease in highest occupied molecular orbital (HOMO) – lowest unoccupied molecular orbital (LUMO) energy gaps for nanoconjugates compared to DNDs alone. B@DNDs-NH2BzPc, SandN@DNDs-NH2BzPc, and P@DNDs-NH2BzPc showed superior photodynamic therapy (PDT) effects. DNDs-NH2BzPc also had a small HOMO-LUMO gap, but did not show improved PDT activity compared to the Pc alone, suggesting doping of DNDs is important. This study shows improved PDT effect on Michigan Cancer Foundation-7 breast cancer lines at 7.63%, 7.62% and 6.5% cell viability for P@DNDs-NH2BzPc, SandN@DNDs-NH2BzPc and B@DNDs-NH2BzPc, respectively

Photodegradation of ibuprofen using 5-10-15-20-tetrakis (4-bromophenyl) porphyrin conjugated to graphene quantum dots

Ibuprofen (IBU) is a common anti-inflammatory drug that is consumed by many individuals in the world. As such, analytical studies have detected high concentrations of the drug in many waterbodies, which poses a risk of harmful effects on the environment and public health. The hydroxyl radical technologies, a collective of techniques also known as advanced oxidation processes (AOPs), can be utilized to degrade this emerging pollutant. In this study, the photodegradation of ibuprofen using 5,10,15,20-tetrakis(4-bromophenyl) porphyrin conjugated to graphene quantum dots was investigated using a custom-built photoreactor. Three different concentrations of IBU (200, 300 and 500 μM) were utilized as initial concentrations. The pH of the IBU was varied between acidic (pH 3.0), natural (pH 5.0) and alkaline (pH 9.0) to note the effect on IBU degradation as a function of time. The Highest ФΔ was obtained for InTBrP- GDQs (ФΔ = 0.80), followed by InTBrP (ФΔ = 0.74). The photodegradation efficiency of the TBrP-GQDs and InTBrP-GQDs were determined to be 43.2 and 76.1% respectively

Orphans and vulnerable children in distress

More than one third of children in two rural townships are missing at least one parent - often the breadwinner. The authors present their findings with this article.

A census report of orphaned and vulnerable children in two South African communities

In 2002, the Human Sciences Research Council was commissioned by the WK Kellogg Foundation to develop and implement a five-year intervention project focusing on orphans and vulnerable children (OVC) in southern Africa. In collaboration with several partner organizations, the project currently focuses on how children, families and communities in Botswana, South Africa and Zimbabwe are coping with the impact of HIV/AIDS. The aim of the project is to develop models of best practise so as to enhance and improve support structures for OVC in the southern African region as a whole. This report forms part of a series that examines the work undertaken as part of the Kellogg OVC Intervention Project from 2002 to 2005